Mabwell (Shanghai) Bioscience Co., Ltd. (688062.SS)
CNY 21.0
(0.92%)
CNY 21.0
(0.92%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 159.29 Million CNY | 101.52% |
| 2022 | 79.04 Million CNY | 97.1% |
| 2021 | 40.1 Million CNY | 15.28% |
| 2020 | 34.79 Million CNY | 20.38% |
| 2019 | 28.9 Million CNY | 214.66% |
| 2018 | 9.18 Million CNY | 1775.47% |
| 2017 | 489.74 Thousand CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 173.24 Million CNY | 11.29% |
| 2024 Q1 | 155.66 Million CNY | -2.28% |
| 2024 Q3 | 208.96 Million CNY | 20.62% |
| 2023 Q4 | 159.29 Million CNY | 4.22% |
| 2023 Q3 | 152.84 Million CNY | 14.59% |
| 2023 FY | 159.29 Million CNY | 101.52% |
| 2023 Q2 | 133.38 Million CNY | 32.14% |
| 2023 Q1 | 100.94 Million CNY | 27.7% |
| 2022 Q3 | 57.31 Million CNY | 14.66% |
| 2022 Q4 | 79.04 Million CNY | 37.91% |
| 2022 FY | 79.04 Million CNY | 97.1% |
| 2022 Q2 | 49.98 Million CNY | 0.83% |
| 2022 Q1 | 49.57 Million CNY | 23.61% |
| 2021 Q4 | 40.1 Million CNY | 1.41% |
| 2021 Q2 | 38.96 Million CNY | 0.0% |
| 2021 Q1 | - CNY | -100.0% |
| 2021 FY | 40.1 Million CNY | 15.28% |
| 2021 Q3 | 39.55 Million CNY | 1.49% |
| 2020 Q4 | 34.79 Million CNY | 0.0% |
| 2020 FY | 34.79 Million CNY | 20.38% |
| 2020 Q2 | 32.81 Million CNY | 0.0% |
| 2019 FY | 28.9 Million CNY | 214.66% |
| 2018 FY | 9.18 Million CNY | 1775.47% |
| 2017 FY | 489.74 Thousand CNY | 0.0% |